Matches in SemOpenAlex for { <https://semopenalex.org/work/W4239308170> ?p ?o ?g. }
- W4239308170 endingPage "1018???1035" @default.
- W4239308170 startingPage "1018???1035" @default.
- W4239308170 abstract "THE RECORDS OF 137 patients with supratentorial oligodendroglioma treated surgically between 1953 and 1986 were reviewed. The tumors were rated histologically benign or malignant. In the 105 patients followed up with a minimum observation time of 5 years to December 1991, the mean postoperative survival was 90.2 months (standard error, 9), the median 64 months (standard error, 9.6), the 5-year survival rate 52.4%, and the 10-year survival rate 24%. Sixteen possible prognostic factors, broken down into two or more variables each, were considered in the survival study on univariate methods (5-year survival rate, survival curves, and Cox's hazard function) and on multivariate analysis according to Cox's stepwise proportional hazards model. The latter showed that variables correlated positively with survival were benign histological findings (P, 0.000), postoperative radiation therapy (P, 0.004), and time of operation from 1977 to 1986 (P, 0.044) in 105 patients of the whole series, and period of surgery from 1977 to 1986 (P, 0.000), subtotal or total surgical resection of the tumor (P, 0.001), and radiation therapy (P, 0.005) in the subgroup of 79 patients operated on for benign tumors. However, the most interesting point to emerge from the study was the relevance of admission clinical status to the survival of patients who did not receive radiation therapy and to the prognostic response of those who did. Of the 40 patients with seizures and negative neurological status—Clinical Syndrome A—the 10 who did not receive radiation therapy had survived as long as the 30 who did (5-year survival rate, 80 versus 67%; P, not significant; median survival, 122 versus 85 months; Breslow and Mantel-Cox P, not significant), whereas of the 65 patients with intracranial hypertension and/or neurological deficits—Clinical Syndrome non-A—the 18 who did not receive radiation therapy had short survival times, and the 47 who did fared significantly better (5-year survival rate, 11 versus 53%; P, 0.002; median survival, 32 versus 64 months; Breslow and Mantel-Cox P, 0.000). These findings were not significantly affected by the exclusion of malignant neoplasms and in the group of benign tumors, in which the histological characteristics have not been found to be significantly different between those with A and those with non-A clinical syndrome, did not depend on different frequencies of subtotal or total tumor removal. In fact, multivariate analyses for benign tumors only demonstrated that the variables that correlated with survival were radiation therapy (P, 0.000) and preoperative history less than 12 months (P, 0.006) in 47 patients with Syndrome non-A, and subtotal or total surgical removal of the tumor (P, 0.005) and additional operations (P, 0.027) in 32 patients with Clinical Syndrome A. These results supply a reasonable explanation for the better survival and the unresponsiveness to radiation therapy of our patients who received surgical treatment since the introduction of computed tomography from 1977 to 1986. On the basis of this review, we believe that patients with cerebral oligodendrogliomas, when histologically benign, should be classified by clinical status at admission in two groups, and that treatment should be organized and survival assessed on that basis. It seems that the two clinical syndromes correspond to different periods in the life history of the tumor." @default.
- W4239308170 created "2022-05-12" @default.
- W4239308170 creator A5016189760 @default.
- W4239308170 creator A5016554671 @default.
- W4239308170 creator A5032262925 @default.
- W4239308170 creator A5061648155 @default.
- W4239308170 creator A5064335936 @default.
- W4239308170 date "1994-12-01" @default.
- W4239308170 modified "2023-10-12" @default.
- W4239308170 title "Cerebral Oligodendroglioma" @default.
- W4239308170 cites W1718429028 @default.
- W4239308170 cites W1823988355 @default.
- W4239308170 cites W1965364067 @default.
- W4239308170 cites W1966992856 @default.
- W4239308170 cites W1967925352 @default.
- W4239308170 cites W1972532120 @default.
- W4239308170 cites W1974645711 @default.
- W4239308170 cites W1978503339 @default.
- W4239308170 cites W1978887816 @default.
- W4239308170 cites W1979701393 @default.
- W4239308170 cites W1986927910 @default.
- W4239308170 cites W2001519101 @default.
- W4239308170 cites W2002291505 @default.
- W4239308170 cites W2005443732 @default.
- W4239308170 cites W2012436140 @default.
- W4239308170 cites W2016888343 @default.
- W4239308170 cites W2018411448 @default.
- W4239308170 cites W2020296038 @default.
- W4239308170 cites W2023563928 @default.
- W4239308170 cites W2025856239 @default.
- W4239308170 cites W2029167968 @default.
- W4239308170 cites W2032087773 @default.
- W4239308170 cites W2035553364 @default.
- W4239308170 cites W2043029829 @default.
- W4239308170 cites W2048697006 @default.
- W4239308170 cites W2050306931 @default.
- W4239308170 cites W2059840366 @default.
- W4239308170 cites W2061062798 @default.
- W4239308170 cites W2067919721 @default.
- W4239308170 cites W2080104165 @default.
- W4239308170 cites W2084841880 @default.
- W4239308170 cites W2085277801 @default.
- W4239308170 cites W2087997083 @default.
- W4239308170 cites W2094558684 @default.
- W4239308170 cites W2102628178 @default.
- W4239308170 cites W2103786046 @default.
- W4239308170 cites W2109937583 @default.
- W4239308170 cites W2109996739 @default.
- W4239308170 cites W2112777292 @default.
- W4239308170 cites W2131622252 @default.
- W4239308170 cites W2161978888 @default.
- W4239308170 cites W2168908657 @default.
- W4239308170 cites W2168915355 @default.
- W4239308170 cites W2316734139 @default.
- W4239308170 cites W2885558248 @default.
- W4239308170 cites W4240150154 @default.
- W4239308170 cites W4243974522 @default.
- W4239308170 cites W4293241248 @default.
- W4239308170 cites W4296247271 @default.
- W4239308170 cites W4376596066 @default.
- W4239308170 doi "https://doi.org/10.1097/00006123-199412000-00003" @default.
- W4239308170 hasPublicationYear "1994" @default.
- W4239308170 type Work @default.
- W4239308170 citedByCount "5" @default.
- W4239308170 countsByYear W42393081702012 @default.
- W4239308170 crossrefType "journal-article" @default.
- W4239308170 hasAuthorship W4239308170A5016189760 @default.
- W4239308170 hasAuthorship W4239308170A5016554671 @default.
- W4239308170 hasAuthorship W4239308170A5032262925 @default.
- W4239308170 hasAuthorship W4239308170A5061648155 @default.
- W4239308170 hasAuthorship W4239308170A5064335936 @default.
- W4239308170 hasConcept C10515644 @default.
- W4239308170 hasConcept C126322002 @default.
- W4239308170 hasConcept C141071460 @default.
- W4239308170 hasConcept C144301174 @default.
- W4239308170 hasConcept C207103383 @default.
- W4239308170 hasConcept C2776283816 @default.
- W4239308170 hasConcept C2777931997 @default.
- W4239308170 hasConcept C2778227246 @default.
- W4239308170 hasConcept C2778880634 @default.
- W4239308170 hasConcept C38180746 @default.
- W4239308170 hasConcept C44249647 @default.
- W4239308170 hasConcept C502942594 @default.
- W4239308170 hasConcept C50382708 @default.
- W4239308170 hasConcept C509974204 @default.
- W4239308170 hasConcept C71924100 @default.
- W4239308170 hasConceptScore W4239308170C10515644 @default.
- W4239308170 hasConceptScore W4239308170C126322002 @default.
- W4239308170 hasConceptScore W4239308170C141071460 @default.
- W4239308170 hasConceptScore W4239308170C144301174 @default.
- W4239308170 hasConceptScore W4239308170C207103383 @default.
- W4239308170 hasConceptScore W4239308170C2776283816 @default.
- W4239308170 hasConceptScore W4239308170C2777931997 @default.
- W4239308170 hasConceptScore W4239308170C2778227246 @default.
- W4239308170 hasConceptScore W4239308170C2778880634 @default.
- W4239308170 hasConceptScore W4239308170C38180746 @default.
- W4239308170 hasConceptScore W4239308170C44249647 @default.
- W4239308170 hasConceptScore W4239308170C502942594 @default.